Stay updated on Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial

Sign up to get notified when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 in the page footer; this is a minor metadata update with no impact on trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T01:36:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Glossary display was added and new data fields were introduced: Results First Posted, Certification/Extension First Posted, Last Update Submitted that met QC Criteria, and Last Update Posted. Additionally, No FEAR Act Data appears and the site revision was updated to v3.4.0, while older items such as Results First Posted (Estimated), Certification/Extension First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.3%
    Check dated 2026-01-28T00:23:31.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added three 'Estimated' date fields (Results First Posted, Certification/Extension First Posted, Last Update Posted) and removed the non-estimated counterparts. This change affects only timestamps on the study record and does not alter core study information.
    Difference
    0.1%
    Check dated 2026-01-21T00:23:58.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Results have been posted for PATHFNDR-2, including IGF-1 biochemical response at Week 24, changes from baseline in IGF-1, GH <1 ng/mL at Week 22, and changes in the Acromegaly Symptoms Diary. Related documents (Study Protocol and Statistical Analysis Plan) and results posting dates are also listed.
    Difference
    2%
    Check dated 2026-01-14T01:00:29.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Locations (participating sites) were expanded with new sites in the United States, Argentina, Brazil, China, and India, among others. Some previously listed locations were removed, and a revision note shows the page updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T13:34:45.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the Study Details page. This appears to be a general site version update with no visible changes to trial content.
    Difference
    0.0%
    Check dated 2025-11-24T19:06:29.000Z thumbnail image

Stay in the know with updates to Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.